Aurobindo Pharma (India) Investor Sentiment

AUROPHARMA   1,119  9.70  0.86%   
About 62% of Aurobindo Pharma's investor base is looking to short. The analysis of overall sentiment of trading Aurobindo Pharma Limited stock suggests that many investors are alarmed at this time. The current market sentiment, together with Aurobindo Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Aurobindo Pharma stock news signals to limit their universe of possible portfolio assets.
  
Aurobindo Pharma stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Aurobindo earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Aurobindo Pharma that are available to investors today. This information is accessible both publicly - through Aurobindo Pharma's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Aurobindo-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Aurobindo Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aurobindo Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aurobindo Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aurobindo Pharma alpha.

Aurobindo Largest EPS Surprises

Earnings surprises can significantly impact Aurobindo Pharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2007-10-31
2007-09-301.20.92-0.2823 
2012-05-30
2012-03-311.551.880.3321 
2013-05-30
2013-03-312.391.87-0.5221 
2012-02-13
2011-12-311.211.80.5948 
2013-02-07
2012-12-312.211.58-0.6328 
2008-01-30
2007-12-311.350.66-0.6951 
View All Earnings Estimates
2 days ago at news.google.com         
Fire temporarily halts production at Aurobindo Pharmas Andhra unit shares down nearly 1 percent - Up...
Google News at Macroaxis
few days ago at news.google.com         
Stock Radar Aurobindo Pharma stock showing signs of momentum after 30 percent fall from highs what s...
Google News at Macroaxis
six days ago at news.google.com         
Aurobindo Pharma Adjusts Evaluation Amid Mixed Technical Indicators and Market Challenges - Markets ...
Google News at Macroaxis
over a week ago at news.google.com         
Heres why Aurobindo Pharma shares jumped 6 percent on Thursday - CNBC TV18
Google News at Macroaxis
over a week ago at news.google.com         
Aurobindo Pharma shares rise 3.26 percent in early trade - Moneycontrol
Google News at Macroaxis
over a week ago at news.google.com         
Aurobindo Pharma shares fall on eight observations from USFDA - Moneycontrol
Google News at Macroaxis
over two weeks ago at news.google.com         
We Discuss Whether Aurobindo Pharma Limiteds CEO Is Due For A Pay Rise - simplywall.st
Google News at Macroaxis
over three weeks ago at news.google.com         
Estimating The Fair Value Of Aurobindo Pharma Limited - simplywall.st
Google News at Macroaxis
over three weeks ago at news.google.com         
Aurobindo Pharma shares rise 2.09 stock among top gainers on Nifty Midcap 150 - Moneycontrol
Google News at Macroaxis
over a month ago at news.google.com         
Aurobindo Pharma Shares SEBI Analyst Sees Buy-On-Dips Opportunity Near 1,000 - Stocktwits
Google News at Macroaxis
over a month ago at news.google.com         
Aurobindo Pharma Share Price Falls 5 percent On Zentiva Deal Reports Q1 Results Update - Samco
Google News at Macroaxis
over a month ago at news.google.com         
Aurobindo Pharma shares slide 4 percent on reports of Zentiva buyout talks - Moneycontrol
Google News at Macroaxis
over a month ago at news.google.com         
Stocks in spotlight Brightcom, Alembic Pharma, Aurobindo, Lemon Tree among 15 to watch on August 18,...
Google News at Macroaxis
over a month ago at news.google.com         
Aurobindo Pharma Ltd soars 1.82 percent - MSN
Google News at Macroaxis
over a month ago at news.google.com         
Aurobindo Pharma shares rise 2.01 percent on Nifty Midcap 150 - Moneycontrol
Google News at Macroaxis
There is far too much social signal, news, headlines, and media speculation about Aurobindo Pharma that are available to investors today. This information is accessible both publicly - through Aurobindo Pharma's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Aurobindo-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Aurobindo Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aurobindo Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aurobindo Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aurobindo Pharma alpha.

Aurobindo Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Bullish Pattern Emerging on Aurobindo Pharma Limited - Exceptional profit potential - Autocar Professional
07/22/2025
2
Aurobindo Pharma Unit to Buy Lannett Company LLC for 250 Million, Shares Trading Flat - Equitypandit
07/31/2025
3
Aurobindo Pharma to Engage in Virtual Investor Conference - TipRanks
08/12/2025
4
Aurobindo Pharma Shares SEBI Analyst Sees Buy-On-Dips Opportunity Near 1,000 - Stocktwits
08/21/2025
5
We Discuss Whether Aurobindo Pharma Limiteds CEO Is Due For A Pay Rise - simplywall.st
09/03/2025
6
Heres why Aurobindo Pharma shares jumped 6 percent on Thursday - CNBC TV18
09/11/2025
7
Fire temporarily halts production at Aurobindo Pharmas Andhra unit shares down nearly 1 percent - Upstox
09/19/2025

Complementary Tools for Aurobindo Stock analysis

When running Aurobindo Pharma's price analysis, check to measure Aurobindo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurobindo Pharma is operating at the current time. Most of Aurobindo Pharma's value examination focuses on studying past and present price action to predict the probability of Aurobindo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurobindo Pharma's price. Additionally, you may evaluate how the addition of Aurobindo Pharma to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm